- Home
- CGEN vs CFBK Comparison
CGEN vs CFBK Comparison
Compare CGEN & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- CFBK
- Stock Information
- Founded
- CGEN 1993
- CFBK 1892
- Country
- CGEN Israel
- CFBK United States
- Employees
- CGEN N/A
- CFBK 103
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- CFBK Major Banks
- Sector
- CGEN Health Care
- CFBK Finance
- Exchange
- CGEN Nasdaq
- CFBK Nasdaq
- Market Cap
- CGEN 135.6M
- CFBK 127.9M
- IPO Year
- CGEN 2000
- CFBK 1998
- Fundamental
- Price
- CGEN $1.47
- CFBK $21.03
- Analyst Decision
- CGEN Strong Buy
- CFBK
- Analyst Count
- CGEN 1
- CFBK 0
- Target Price
- CGEN $4.00
- CFBK N/A
- AVG Volume (30 Days)
- CGEN 268.4K
- CFBK 14.3K
- Earning Date
- CGEN 05-19-2025
- CFBK 05-06-2025
- Dividend Yield
- CGEN N/A
- CFBK 1.34%
- EPS Growth
- CGEN N/A
- CFBK N/A
- EPS
- CGEN N/A
- CFBK 2.06
- Revenue
- CGEN $27,864,000.00
- CFBK $45,082,000.00
- Revenue This Year
- CGEN $11.81
- CFBK N/A
- Revenue Next Year
- CGEN $28.37
- CFBK N/A
- P/E Ratio
- CGEN N/A
- CFBK $10.21
- Revenue Growth
- CGEN N/A
- CFBK N/A
- 52 Week Low
- CGEN $1.13
- CFBK $16.92
- 52 Week High
- CGEN $2.66
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- CGEN 49.50
- CFBK 46.70
- Support Level
- CGEN $1.13
- CFBK $20.00
- Resistance Level
- CGEN $1.35
- CFBK $21.11
- Average True Range (ATR)
- CGEN 0.11
- CFBK 0.71
- MACD
- CGEN 0.03
- CFBK 0.08
- Stochastic Oscillator
- CGEN 85.00
- CFBK 58.77
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.